Diabetes mellitus is a metabolic disorder characterized by chronic hyperglycemia resulting from defects in insulin secretion, insulin action, or both. While most patients and clinicians focus on well-known complications such as cardiovascular disease, nephropathy, and retinopathy, the impact of diabetes on the reproductive system is often underemphasized. However, mounting evidence indicates that diabetes significantly influences the risk of reproductive tract infections (RTIs) and disrupts fertility in both men and women. Understanding this connection is essential for comprehensive diabetes management and improved quality of life.

Over 500 million adults worldwide live with diabetes, and this number continues to rise. With such a large population affected, the reproductive health consequences represent a substantial public health concern. This article explores the biological mechanisms linking diabetes to RTIs, examines how diabetes impairs male and female fertility, and provides actionable strategies for managing these risks.

How Diabetes Increases the Risk of Reproductive Tract Infections

Reproductive tract infections are more common and often more severe in individuals with poorly controlled diabetes. The underlying reasons involve a combination of immune dysfunction, altered microbial environment, and direct tissue damage caused by high glucose levels.

Mechanisms: Why High Blood Sugar Promotes Infection

Chronic hyperglycemia impairs multiple arms of the immune system. Neutrophil chemotaxis, phagocytosis, and intracellular killing of pathogens are all blunted in the presence of elevated glucose. At the same time, high sugar concentrations in bodily fluids such as vaginal secretions, seminal fluid, and urine create a favorable environment for bacterial and fungal overgrowth. For example, Candida albicans, the fungus responsible for most vaginal yeast infections, thrives on glucose. Additionally, glycosuria (glucose in the urine) provides a nutrient source for urinary pathogens, increasing the likelihood of urinary tract infections (UTIs).

Diabetes also compromises tissue microcirculation and nerve function. Reduced blood flow to genital tissues impairs local immune responses and slows wound healing, making it harder to clear infections. Autonomic neuropathy can lead to urinary retention, further promoting bacterial colonization. These mechanisms collectively explain why people with diabetes face a two- to four-fold higher risk of RTIs compared to those without diabetes.

Infections in Women with Diabetes

Women with diabetes are particularly vulnerable to several types of RTIs. Vulvovaginal candidiasis (yeast infection) is one of the most common. Studies report that diabetic women experience recurrent yeast infections at a significantly higher rate, and these infections may be more resistant to standard treatments. Bacterial vaginosis, an imbalance of vaginal flora, is also more prevalent. The resulting discharge and tissue inflammation can lead to discomfort and increase the risk of ascending infections that involve the upper genital tract.

Urinary tract infections occur more frequently in diabetic women and tend to be more severe. Pyelonephritis (kidney infection) is a serious complication that can lead to hospitalization and even sepsis. Recurrent UTIs are a hallmark of uncontrolled diabetes. Additionally, women with diabetes are at elevated risk for pelvic inflammatory disease (PID), an infection of the uterus, fallopian tubes, and ovaries. PID can cause chronic pelvic pain and fallopian tube scarring, directly affecting fertility.

During pregnancy, uncontrolled diabetes further increases the risk of chorioamnionitis and postpartum RTIs, endangering both mother and child. These infections underscore the importance of rigorous glycemic control throughout a woman’s reproductive years.

Infections in Men with Diabetes

Men with diabetes also experience a higher incidence of RTIs. Balanitis (inflammation of the glans penis) is frequently seen in uncircumcised men with poor glucose control. High glucose content in smegma encourages fungal and bacterial growth, leading to redness, swelling, and discomfort. Balanoposthitis (inflammation of both glans and foreskin) can become chronic if blood sugar is not managed.

Diabetes is a known risk factor for prostatitis, an infection of the prostate gland that can cause pelvic pain, urinary symptoms, and sexual dysfunction. Chronic prostatitis may impair semen quality and contribute to male factor infertility. Additionally, epididymitis (infection of the epididymis) occurs more often in diabetic men, particularly in those with underlying neuropathy that leads to incomplete bladder emptying and subsequent retrograde spread of bacteria.

Sexually transmitted infections (STIs) such as HIV and herpes simplex virus can also be more severe in individuals with diabetes due to impaired immune clearance. The presence of genital ulcers or lesions further increases transmission risk and complicates management.

Direct and Indirect Effects of Diabetes on Fertility

Beyond infections, diabetes disrupts fertility through hormonal imbalances, direct damage to reproductive organs, and systemic metabolic disturbances. Both men and women with diabetes face a higher likelihood of subfertility and may require medical assistance to conceive.

Female Fertility: Hormonal Disruption and Ovulatory Dysfunction

In women, diabetes interferes with the hypothalamic-pituitary-ovarian (HPO) axis. Poorly controlled diabetes can lead to elevated levels of inflammatory cytokines and advanced glycation end-products (AGEs), which impair the normal pulsatile release of gonadotropin-releasing hormone (GnRH). This disrupts luteinizing hormone (LH) and follicle-stimulating hormone (FSH) secretion, resulting in anovulation or irregular menstrual cycles. Up to 40% of premenopausal women with type 1 diabetes may experience menstrual irregularities, and those with type 2 diabetes and obesity are at even higher risk.

Hyperglycemia also directly harms ovarian tissue. Oocyte quality is diminished due to oxidative stress within the follicular fluid. Studies have shown that women with higher HbA1c levels have lower fertilization rates and produce embryos with poorer developmental potential in in-vitro fertilization (IVF) cycles. Additionally, diabetes is associated with premature ovarian insufficiency—meaning the ovaries stop functioning normally before age 40—due to accelerated follicular depletion caused by metabolic toxicity.

Polycystic ovary syndrome (PCOS) is frequently comorbid with type 2 diabetes. The insulin resistance that drives PCOS also contributes to hyperandrogenism and anovulation. Treating the underlying insulin resistance with lifestyle changes or medications like metformin can improve ovulation rates in this population.

Male Fertility: Erectile Dysfunction, Semen Quality, and Hormonal Changes

Male reproductive health is profoundly affected by diabetes. Erectile dysfunction (ED) is one of the most common complications, affecting 35% to 75% of men with diabetes, often occurring 10 to 15 years earlier than in men without diabetes. ED results from a combination of vascular damage (endothelial dysfunction), neuropathy, and hormonal changes. Poor glycemic control accelerates these processes.

Diabetes also impairs spermatogenesis. Men with diabetes have been shown to have lower sperm concentration, reduced motility, and higher percentages of sperm with DNA fragmentation. These abnormalities are driven by oxidative stress, AGE accumulation in the seminal plasma, and direct damage to the seminiferous tubules. Semen analysis frequently reveals significant impairments in men with both type 1 and type 2 diabetes.

Testosterone deficiency is another major concern. Low serum testosterone is more prevalent in diabetic men, particularly those with concurrent obesity. Hypogonadism contributes to reduced libido, decreased muscle mass, and further ED. It also negatively affects sperm production, creating a vicious cycle. Treatment with testosterone replacement therapy may improve symptoms but must be carefully managed because exogenous testosterone can suppress endogenous gonadotropins and impair fertility in men who wish to father children.

Retrograde ejaculation is another complication, occurring when autonomic neuropathy prevents the bladder neck from closing during ejaculation, causing semen to flow backward into the bladder. This can lead to dry orgasm and infertility. Retrieval of sperm from urine may be necessary for assisted reproduction.

Shared Factors: Oxidative Stress and Glycation

Both sexes share common molecular pathways through which diabetes damages reproductive tissues. Oxidative stress from chronic hyperglycemia produces reactive oxygen species (ROS) that damage DNA, proteins, and cell membranes. In women, this affects oocyte quality and endometrial receptivity. In men, it harms sperm DNA and the acrosomal membrane. Advanced glycation end-products (AGEs) accumulate on reproductive tissues, interfering with hormone receptor signaling and inducing inflammation. AGE-modified proteins in the ovarian stroma and testicular interstitium contribute to fibrosis and functional decline.

Mitochondrial dysfunction is another key factor. Both oocytes and sperm rely heavily on mitochondrial function for energy production. Hyperglycemia impairs mitochondrial biogenesis and increases mitochondrial DNA mutations, reducing the viability and competence of gametes.

Managing Diabetes to Protect Reproductive Health

Reproductive complications of diabetes are not inevitable. With proactive and intensive management of blood glucose levels and associated risk factors, many of the negative effects on infection susceptibility and fertility can be reduced or reversed.

Glycemic Control as the Foundation

The single most important intervention is achieving and maintaining near-normal blood glucose levels. An HbA1c target below 7% (53 mmol/mol) is generally recommended for non-pregnant adults, though individual goals should be tailored. Studies show that improving glycemic control reduces the incidence of both RTIs and fertility issues. For women trying to conceive, preconception counseling and optimization of HbA1c to below 6.5% is associated with improved ovulation and pregnancy outcomes. In men, better glucose control correlates with improved sperm parameters and reduced erectile dysfunction.

Regular self-monitoring of blood glucose, continuous glucose monitoring (CGM) systems, and insulin pump therapy can help patients achieve tighter control with fewer hypoglycemic episodes. Medications like metformin, which improves insulin sensitivity, may also have direct beneficial effects on ovarian function in women with PCOS and reduce inflammation in both sexes.

Lifestyle Interventions: Diet, Exercise, and Weight Management

Lifestyle modifications complement pharmacological therapy. A diet low in refined carbohydrates and high in fiber, healthy fats, and lean protein helps stabilize postprandial glucose spikes and reduces systemic inflammation. Particular emphasis on antioxidant-rich foods (berries, leafy greens, nuts, and seeds) may counteract some of the oxidative stress impacting reproductive tissues.

Regular physical activity improves insulin sensitivity and reduces blood glucose levels. Aerobic exercise combined with resistance training has been shown to enhance sperm quality in diabetic men and improve menstrual regularity in women. Weight loss of 5% to 10% in overweight or obese individuals can restore ovulation in women with type 2 diabetes and PCOS, and it also improves erectile function in men.

Avoiding smoking and limiting alcohol intake are critical. Both tobacco and excessive alcohol worsen glycemic control and directly impair reproductive function. Smoking, in particular, accelerates vascular damage and increases DNA fragmentation in sperm.

Medical and Reproductive Assistance

For individuals facing persistent fertility issues despite optimized diabetes management, assisted reproductive technologies (ART) can be effective. Women may benefit from ovulation induction with clomiphene citrate or gonadotropins, followed by intrauterine insemination (IUI) or IVF. Since diabetes can impair endometrial receptivity, hormonal support and close monitoring of glucose during the cycle are essential.

Men with severe sperm abnormalities may require intracytoplasmic sperm injection (ICSI) to achieve fertilization. Sperm retrieval techniques such as testicular sperm extraction (TESE) can be used in cases of retrograde ejaculation or azoospermia. Importantly, men with diabetes should have a comprehensive semen analysis and hormonal evaluation before seeking ART.

Infection management is equally important. Antifungal treatments for yeast infections may require longer courses or prophylactic dosing. For bacterial STIs and UTIs, culture-guided antibiotic therapy and strict adherence to the full course are necessary. Recurrent infections should prompt a review of glycemic control and consideration of daily prophylactic antibiotics in selected cases.

When to Seek Specialized Care

Both men and women with diabetes should receive regular reproductive health surveillance. Women should have annual gynecological exams, including screening for RTIs and assessment of menstrual regularity. Men should be asked about erectile function and have a testicular exam. Any signs of infertility—failure to conceive after 12 months of regular unprotected intercourse (or 6 months if the woman is over 35) —warrant referral to a reproductive endocrinologist or a urologist with expertise in male infertility.

Specialized care is also indicated when infections are recurrent or severe. A multidisciplinary approach involving an endocrinologist, a reproductive specialist, and possibly an infectious disease expert can optimize outcomes. Preconception counseling is strongly recommended for women with diabetes who plan pregnancy, as it significantly lowers the risk of congenital anomalies and pregnancy complications.

External resources provide additional guidance. The Centers for Disease Control and Prevention (CDC) offers patient-friendly information on diabetes and reproductive health. The National Institutes of Health (NIH) provides research updates and clinical recommendations. For detailed fertility information, the American Society for Reproductive Medicine (ASRM) has dedicated pages. Another valuable source is the World Health Organization (WHO) diabetes fact sheet, which includes global statistics and health advice.

Conclusion: Proactive Management for Better Outcomes

Diabetes exerts a far-reaching influence on reproductive health, from increasing susceptibility to infections in both men and women to profoundly impairing fertility through direct cellular damage and hormonal disruption. The mechanisms—immune dysfunction, oxidative stress, AGE accumulation, and neuropathy—are well understood and modifiable. The key takeaway is that these complications are not inevitable. With aggressive glycemic control, healthy lifestyle habits, and timely medical intervention, people with diabetes can greatly reduce their risk of RTIs and improve their chances of having children.

Healthcare providers must routinely address reproductive health as part of comprehensive diabetes care, asking about symptoms of infection, menstrual history, erectile function, and family planning goals. Collaborative management between endocrinology, gynecology, and urology can provide the best outcomes. As the global burden of diabetes continues to grow, integrating reproductive health into diabetes management is not just an option—it is a necessity.